Table 1.
Measure | No ELS (n = 61) |
ELS (n = 181) |
Total (n = 242) |
---|---|---|---|
Zygosity (MZ/DZ) | 38/23 | 125/56 | 163/79 |
Age (years ± SD) | 38.8 (±13.3) | 39.7 (±12.7) | 39.5 (±12.9) |
Sex (M/F) | 27/34 | 61/120 | 88/154 |
COMPAS-W total (range: 26–130; ±SD) | 100 (±9.50) | 99.1 (±11.3) | 99.3 (±10.9) |
DASS-42 total (range: 0–126; ±SD) | 8.77 (±7.34) | 11.8 (±12.2) | 11.1 (±11.2) |
ERQ reappraisal (range: 0–6; ±SD) | 5.01 (±1.07) | 5.06 (±1.06) | 5.04 (±1.06) |
ERQ suppression (range: 0–4; ±SD) | 3.51 (±1.02) | 3.56 (±1.27) | 3.55 (±1.21) |
Total number of the sample reflects the final sample of participants included in all analyses (SBM, linear mixed models, moderated mediation model).
ELS early life stress exposure identified from the Early Life Stress Questionnaire, MZ monozygotic twin, DZ dizygotic twin, COMPAS-W total composite measure of wellbeing, DASS-42 total measure of negative mood symptoms of depression, anxiety, and stress, ERQ measure of emotion regulation that includes reappraisal and suppression subscales.